Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Perthera
AddedFeb 15, 2024
UpdatedJun 18, 2026
Perthera

Perthera

Pre-Seed

Perthera, Inc.: A precision medicine firm providing personalized cancer treatment options in the US.

HQ
McLean, VA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Perthera is a precision medicine company focused on revolutionizing cancer treatment through personalized care. The firm offers advanced services to cancer patients and physicians, providing tailored treatment options based on individual patient profiles. Perthera's approach aims to optimize cancer care by leveraging cutting-edge technology and medical expertise to deliver targeted therapies.

The company has made significant strides in the field of oncology, expanding its services to ease the burden on clinicians delivering precision oncology care. Perthera's impact is further bolstered by its leadership team, which includes renowned oncologist Dr. Derek Raghavan as Chief Medical Officer and healthcare technology veteran Donna Tuths as CEO. These appointments underscore Perthera's commitment to advancing personalized cancer treatment and improving patient outcomes.

Perthera - Similar Companies

OncoPrecision logo

OncoPrecision

oncoprecision.bio

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Alphina Therapeutics logo

Alphina Therapeutics

Precision Theranostics logo

Precision Theranostics

Perspective Therapeutics logo

Perspective Therapeutics

Verthermia logo

Verthermia

verthermia.com

Preveta logo

Preveta

preveta.com

Odyssey Thera logo

Odyssey Thera

Phigenix logo

Phigenix

phigenix.com

Palm Therapeutics logo

Palm Therapeutics

Path BioAnalytics logo

Path BioAnalytics

Empiri logo

Empiri

empiricancer.com

CerFlux logo

CerFlux

cerflux.com

Trethera logo

Trethera

trethera.com

Scorpion Therapeutics logo

Scorpion Therapeutics

Perthera - Quick Facts

Who are Perthera's competitors?

Companies similar to Perthera include OncoPrecision, PanTher Therapeutics, Alphina Therapeutics and Precision Theranostics.

When was Perthera founded?

Perthera was founded in 2012.

Where is Perthera's headquarters located?

Perthera's headquarters is located in McLean, VA, US.

When was Perthera's last funding round?

Perthera's most recent funding round was for $750k (USD) in December 2017.

How much has Perthera raised to-date?

As of Dec 26, 2017, Perthera has raised a total of $10.7M (USD).

How many employees does Perthera have?

Perthera has 125 employees as of Feb 5, 2024.

Perthera - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Precision Medicine
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 10 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8060Hospitals